Table 1.
Cross-country comparison of non-communicable disease funding systems in Italy and Germany
| Italy | Germany | |
|---|---|---|
| Identified eligible RFOs | 46 | 13 |
| Main research funding sources | Central and regional governments, ‘5 per thousand’ mechanism, foundations (banking) | Central government and other national funding bodies, foundations (charity, company) |
| Public NCD project funding/total project funding budget | PRIN: €4.1 mn/€100 mn (2012) | DFG: €105.2 bn/€2.7 bn (2013) |
| ‘5 per thousand’: €35mn (2011) | BMBF: €66.5 bn/€3.3 bn (2013) | |
| Public NCD funding | Cancer (€37.1 mn) | Cardiovascular diseases (€56.4 mn) |
| Cardiovascular diseases (€1.4 mn) | Cancer (€55.6 mn) | |
| Diabetes (€710 k) | Mental health (€32.8 mn) | |
| Mental health (€550 k) | Diabetes (€18.9 mn) | |
| Chronic respiratory diseases (€66 k) | Chronic respiratory diseases (€7.9 mn) |
BMBF Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research), DFG Deutsche Forschungsgemeinschaft (German Research Foundation), NCD non-communicable disease, PRIN Progetti di Rilevante Interesse Nazionale (research projects of national interest), RFO research funding organisation